Unnisa_2022_Eur.Rev.Med.Pharmacol.Sci_26_7245

Reference

Title : Design, in silico study, synthesis and in vitro evaluation of some N5-(1H-pyrazol-3-yl)-3H-benzo[d]imidazole-2,5-diamine derivatives as potential pancreatic lipase inhibitors for anti-obesity activity - Unnisa_2022_Eur.Rev.Med.Pharmacol.Sci_26_7245
Author(s) : Unnisa A , Huwaimel B , Almahmoud S , Abouzied AS , Younes KM , Anupama B , Kola PK , Lakshmi N
Ref : Eur Rev Med Pharmacol Sci , 26 :7245 , 2022
Abstract : Unnisa_2022_Eur.Rev.Med.Pharmacol.Sci_26_7245
ESTHER : Unnisa_2022_Eur.Rev.Med.Pharmacol.Sci_26_7245
PubMedSearch : Unnisa_2022_Eur.Rev.Med.Pharmacol.Sci_26_7245
PubMedID: 36263535

Related information

Citations formats

Unnisa A, Huwaimel B, Almahmoud S, Abouzied AS, Younes KM, Anupama B, Kola PK, Lakshmi N (2022)
Design, in silico study, synthesis and in vitro evaluation of some N5-(1H-pyrazol-3-yl)-3H-benzo[d]imidazole-2,5-diamine derivatives as potential pancreatic lipase inhibitors for anti-obesity activity
Eur Rev Med Pharmacol Sci 26 :7245

Unnisa A, Huwaimel B, Almahmoud S, Abouzied AS, Younes KM, Anupama B, Kola PK, Lakshmi N (2022)
Eur Rev Med Pharmacol Sci 26 :7245